European Journal of Cancer · 2015 · 151 citations · 24 references
MedicineCancer BiologyOncologyChemotherapyMolecular OncologyNeoplasiaConcurrent ChemoradiationDeath ReceptorsEsophageal CancerMalignant NeoplasmsNeoadjuvant TherapyRadiation TherapyApoptotic Signaling In CancerCombination With ChemoradiotherapyNeoadjuvant ChemoradiotherapyNeoadjuvant Concurrent ChemoradiationProgrammed Cell Death Ligand 1 InhibitionProgrammed Death-ligand 1 BiomarkerProgrammed Death-ligand 1 InhibitionProgrammed Death-ligand 1 Signaling
24
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text
Life Sciences, Immunology, Oncology +17
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations
Medicine, Immunology, Oncology +17